Up next

Autoplay

Saar Gill, MD: Combining CAR T-Cell Therapy With Ibrutinib in CLL Patients

1 Views • 07/14/23
Share
Embed
administrator
administrator
Subscribers
0

Adding ibrutinib to treatment with CAR T-cell therapy was feasible, led to deeper remissions, and reduced the severity of cytokine release syndrome in patients with chronic lymphocytic leukemia.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay